CATINAZZO THOMAS (Vice President, Finance) sold 2.9% of their position (9.10K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $54.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/30/2024ACC: 0000950170-24-118982
Officer· Vice President, Finance
Since Jul 2020
-9.10K
Net shares
Net seller
$54.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
9.10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.70K
Price / share
$6.06
Trade value
$10.28K
% of position
0.5%
10/28/2024
313.19K→311.50K
Common Stock
Direct
Shares
−5.11K
Price / share
$6.06
Trade value
$30.94K
% of position
1.6%
10/28/2024
311.50K→306.39K
Common Stock
Direct
Shares
−2.30K
Price / share
$5.95
Trade value
$13.69K
% of position
0.8%
10/29/2024
306.39K→304.09K
Total
Net shares
−9.10K
Net value
-$54.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/28/2024 | S · Sale | −1.70K | $6.06 | $10.28K | 0.5% | 313.19K | 311.50K |
| Common Stock Direct | 10/28/2024 | S · Sale | −5.11K | $6.06 | $30.94K | 1.6% | 311.50K | 306.39K |
| Common Stock Direct | 10/29/2024 | S · Sale | −2.30K | $5.95 | $13.69K | 0.8% | 306.39K | 304.09K |
| Total | −9.10K | -$54.91K | ||||||
Derivative Transactions0
No derivative transactions reported